Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New hope for children with eye tumors, cancer

24.06.2003


A deadly form of cancer in children, which starts out as a tumor in the eye, can now be treated successfully by a combination of therapies. This is the conclusion of a study appearing in the June issue of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, the Eye M.D. Association.



Malignant retinal tumors in children, called retinoblastomas, which have spread to the bones, bone marrow and soft tissue can be successfully treated by a combination of high-dose chemotherapy, radiation therapy and transplantation of blood-producing stem cells.

In the study, conducted at St. Jude Children’s Hospital in Memphis, Tennessee, four pediatric patients were treated with intensive chemotherapy – a combination of several very-high-dose anti-cancer drugs – radiation therapy, and the transplantation of the patients’ own blood-producing stem cells. The blood stem cells were harvested after two to four courses of chemotherapy.


In all cases, the bone marrow disease went into complete remission after two courses of chemotherapy, which was followed by radiation and stem-cell therapy. Of the four patients, two survived free of disease longer than six years. In the other two patients, disease recurred in the central nervous system and they did not survive. Disease of the central nervous system continues to be the major obstacle to improved outcomes for patients with metastatic retinoblastomas.

Carlos Rodriguez-Galindo, MD, lead author of the study, said, "Our results show that retinal tumors that metastasize to other areas of the body can be cured. Chemotherapy by itself only results in transient improvement, with all patients dying of disease progression eventually, whereas chemotherapy in combination with radiation and stem-cell therapies can actually save patients’ lives. We believe more than 90 percent of patients can be cured with surgery if the disease is detected early enough, before the disease spreads."

Dr. Rodriguez-Galindo and colleagues are working with Ira J. Dunkel, MD, at Memorial Sloan Kettering Cancer Center in New York and with Eric F. Grabowski, MD, ScD, at Massachusetts General Hospital for Children to develop a national protocol that will apply these principles of therapy to all children with this disease.

Based on data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program (http://seer.cancer.gov), Dr. Rodriguez-Galindo estimates the number of annual retinoblastoma cases in the United States to be between 300 and 350. Of these, approximately 15, or five percent, develop retinal tumors that spread outside of the eye. "However," he said, "in developing countries, close to 40 to 50 percent of retinoblastoma patients develop metastatic disease."

Academy spokesperson William Mieler, MD, said, "This study, along with comparable studies conducted by Drs. Dunkel and Grabowski, provides encouraging evidence that a successful approach to treating this advanced, devastating disease is close at hand. Once the protocol is further established and tested on additional patients, we can hope to see further documentation of effective treatment for patients with advanced metastatic retinoblastoma."


The American Academy of Ophthalmology is the world’s largest association of eye physicians and surgeons--Eye M.D.s--with more than 27,000 members worldwide. For more information about eye health care, visit the Academy’s partner Web site, the Medem Network, at http://www.medem.com/eyemd. To find an Eye M.D. in your area, visit the Academy’s Web site at http://www.aao.org.

Media Relations | EurekAlert!
Further information:
http://www.medem.com/eyemd
http://www.aao.org

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Black nitrogen: Bayreuth researchers discover new high-pressure material and solve a puzzle of the periodic table

29.05.2020 | Materials Sciences

Argonne researchers create active material out of microscopic spinning particles

29.05.2020 | Materials Sciences

Smart windows that self-illuminate on rainy days

29.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>